BioGaia Logo

BioGaia

A healthcare and biotechnology company developing clinically proven probiotic products.

BIOG | ST

Overview

Corporate Details

ISIN(s):
SE0000470395 (+2 more)
LEI:
549300UBUJOY2L7TT361
Country:
Sweden
Address:
Box 3242, 103 64 Stockholm

Description

BioGaia is a healthcare and biotechnology company that is a world leader in probiotics. A pioneer in microbiome research for over 30 years, the company develops, markets, and sells a range of clinically proven probiotic products. Its portfolio is centered on its patented probiotic strain, Lactobacillus reuteri. These products, typically offered as food supplements, are designed to support the health and well-being of consumers at all stages of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-02-03 19:00
BioGaia revises dividend policy
English 137.2 KB
2020-11-30 14:10 English 35.8 KB
2020-11-30 08:30
Nytt antal aktier och röster i BioGaia
Swedish 72.0 KB
2020-11-30 08:30
New number of shares and votes in BioGaia
English 129.1 KB
2020-11-25 17:16
Extraordinary General Meeting of BioGaia
English 117.9 KB
2020-11-25 17:16
Extra bolagsstämma i BioGaia
Swedish 72.8 KB
2020-11-11 11:36 English 34.5 KB
2020-11-02 20:45
Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)
English 112.9 KB
2020-11-02 20:45
Kallelse till extra bolagsstämma i BioGaia AB (publ)
Swedish 109.6 KB
2020-10-30 21:30
BioGaia har genomfört en riktad nyemission om 2,86 miljoner B-aktier och tillfö…
Swedish 240.2 KB
2020-10-30 21:30
BioGaia has carried out a directed issue of 2.86 million class B shares, raisin…
English 239.7 KB
2020-10-26 14:09 English 34.2 KB
2020-10-23 08:00 Swedish 1.1 MB
2020-10-23 08:00 English 1.1 MB
2020-10-12 22:15
Minskad försäljning till följd av covid-19
Swedish 153.8 KB

Automate Your Workflow. Get a real-time feed of all BioGaia filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioGaia

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioGaia via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-08 Barbro Fridén Other Buy 188 19,627.20 SEK
2024-09-13 Linda Hägglund Other Sell 2,000 233,800.00 SEK
2024-09-12 Linda Hägglund Other Sell 994 115,502.80 SEK
2024-09-12 Linda Hägglund Other Sell 6 697.80 SEK
2024-06-10 Outi Armstrong Other Buy 1,000 125,400.00 SEK
2023-08-02 Anthon Jahreskog Other Buy 481 51,515.10 SEK
2023-08-02 Anthon Jahreskog Other Buy 169 18,083.00 SEK

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.